Mankind Pharma 
Business

Mankind Pharma to acquire Bharat Serums and Vaccines for Rs 13,630 crore

The company has entered into a definitive agreement to acquire a 100 per cent stake in the Bharat Serums and Vaccines (BSV) for an enterprise value of around Rs 13,630 crore, Mankind Pharma said in a statement.

PTI

NEW DELHI: Mankind Pharma on Thursday said it will fully acquire Bharat Serums and Vaccines from Advent International for around Rs 13,630 crore.

The company has entered into a definitive agreement to acquire a 100 per cent stake in the Bharat Serums and Vaccines (BSV) for an enterprise value of around Rs 13,630 crore, Mankind Pharma said in a statement.

This strategic move marks a significant leap for the drug maker, positioning it as a leader in the Indian women's health and fertility drug market, alongside access to other high entry barrier products in critical care with established complex R&D tech platforms, it added. 

Also Read

VB-G RAM-G replaces MGNREGA with President's assent, gazette notification

GCC seeks police inquiry into wage theft scam by Parks department contractors

TN Minister TRB Rajaa inspects Madurai Tidel Park works

Erode meeting testimony to Vijay's actor-to-politician transformation, claims TVK leader Arunraj

Tamil Nadu's first play park for pet dogs opened in Ooty